Lifestance Health
LFST
89 hedge funds and large institutions have $2.14B invested in Lifestance Health in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 27 increasing their positions, 27 reducing their positions, and 13 closing their positions.
50% more capital invested
Capital invested by funds: $1.42B → $2.14B (+$716M)
38% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 13
6% more funds holding
Funds holding: 84 → 89 (+5)
0% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 27
0.16% less ownership
Funds ownership: 76.56% → 76.41% (-0.16%)
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
64% less call options, than puts
Call options by funds: $350K | Put options by funds: $984K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
+$9.39M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
+$5.55M |
| 3 |
IHAM
Integral Health Asset Management
New York
|
+$3.93M |
| 4 |
Jennison Associates
New York
|
+$3.73M |
| 5 |
Marshall Wace
London,
United Kingdom
|
+$1.64M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$16.6M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$5.97M |
| 3 |
SP
Stockbridge Partners
Boston,
Massachusetts
|
-$2.33M |
| 4 |
PM
Prosight Management
Dallas,
Texas
|
-$1.55M |
| 5 |
HIP
HUB Investment Partners
Austin,
Texas
|
-$1.44M |
LFST Hedge Fund Activity: Q1 2023 in Review
89 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Lifestance Health (LFST) for Q1 2023, worth a combined $2.14B — up 50% from $1.42B a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new LFST positions and 13 closed out — a net gain of 5 holders — while 27 added to existing stakes and 27 trimmed.
The largest buyer was Millennium Management, adding an estimated $9.39M. The largest seller was Fidelity Investments, cutting an estimated $16.6M.
- 89 institutional investors held Lifestance Health (LFST) as of Q1 2023, up from 84 in Q4 2022.
- Funds reported $2.14B of Lifestance Health stock for Q1 2023, up 50% quarter-over-quarter.
- 18 funds opened new Lifestance Health positions in Q1 2023 and 13 closed out, a net change of +5 holders.
- The largest Lifestance Health buyer in Q1 2023 was Millennium Management, an estimated $9.39M added.
- The largest Lifestance Health seller in Q1 2023 was Fidelity Investments, an estimated $16.6M sold.
Based on aggregated 13F filings for Q1 2023.